Warburg Cuts Chinese Pharma Firm Stake With Hefty Windfall

Private equity firm Warburg Pincus has trimmed its stake in NASDAQ-listed China Biologic Products again, selling a 16% stake for US$425.7 million, according to a company announcement. Warburg Pincus Private Equity X, L.P. and Warburg Pincus X Partners, L.P. sold 3.87 million shares at US$110 per share. The private equity giant is now left with […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Read the original article: China Money Network